The effects of induced kynurenine pathway on immunocytochemical changes in rat tissues following excessive L-tryptophan consumption

Advances in Experimental Medicine and Biology

Volumn 398, Issue , 1996, Pages 177-182

  Ronen, N ^a   Gross, B ^a   Ben Shachar, D ^a   Livne, E ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FENCLONINE; KYNURENINE; SEROTONIN; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; BRAIN; CYTOLOGY; DIET SUPPLEMENTATION; DRUG EFFECT; FEMALE; IMMUNOHISTOCHEMISTRY; LUNG; METABOLISM; RAT; SKELETAL MUSCLE; WEIGHT GAIN;

ANIMALS; BRAIN; FEMALE; FENCLONINE; FOOD, FORTIFIED; IMMUNOHISTOCHEMISTRY; KYNURENINE; LUNG; MUSCLE, SKELETAL; RATS; SEROTONIN; TRYPTOPHAN; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT GAIN;

EID: 0030346561     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0381-7_29     Document Type: Article

References (12)

1. Bruce F., Werth V.P., Rook A.H., O'Connor C.R., Schumacher H.R., 1990, L-Tryptophan ingestion associated with eosinophilic fasci but not progressive systemic sclerosis. Ann. Int. Med. 112: 758.
2. th Edition. New York, Oxford. Oxford University Press, p.p.338-280.
3. Duffy J., 1992, The lessons of Eosinophilia-Myalgia Syndrome. Hospital Practice 30: 65.
4. Freese B.A., Kenton J., Swartz B.A., Mattew J., 1990, Kynurenine metabolites of tryptophan: Implications for neurologic diseases. Neurology 40: 691.
5. Freis J.F., Lingren J.A., Bull M.J., 1973, Scleroderma-like lesions and Carcinoid syndrome. Arch. Intern. Med. 131: 550.
6. Heyes M.P., Saito K., Crowley J.S., 1992, Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurolgic disease. Brain. 115: 1249.
7. Leonhardt A.B., Neal J.W., Kuln J.A., Schwarz M., Plimmer J.R., 1986, Quinolinic acid: An endogenous metabolite that produces axon-sparing lesions in rat brain. Science. 219: 316.
8. Saito K., Crowley J.S., Markry S.P., Heyes M.P., 1993, A mechanism for increased quinolinic acid formation following acute systemic immune stimulation. J. Biol. Chem. 268: 15496.
9. Smith S.A., Roelofs R.I., Gertner E., 1990, Microangiopathy in eosinophilia-myalgia syndrome. J.Rheumatol. 17: 1544.
10. Stenerg E.M., Van Woert M.H., Young S.N., Magnussen I.B., 1980, Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa. New Engl. J. Med. 303: 782.
11. Varesio L., Calyton M., Ruffman E., Radzioch D., 1990, Picolonic acid, a catabolite of tryptophan, as the second signal in the activation of interferon-γ-primed macrophages. J. Immunol. 145: 4265.
12. Varge J., Peltonen J., Uitto J., Jimenez S., 1990, Development of diffuse fasciitis with eosinophilia during L-tryptophan treatment: Demonstration of Elevated Type I Collagen gene expression in affected tissues. Annals Int. Med. 112: 344.